Historical Valuation
Ardent Health Inc (ARDT) is now in the Undervalued zone, suggesting that its current forward PE ratio of 6.68 is considered Undervalued compared with the five-year average of 8.38. The fair price of Ardent Health Inc (ARDT) is between 10.37 to 14.29 according to relative valuation methord. Compared to the current price of 8.87 USD , Ardent Health Inc is Undervalued By 14.43%.
Relative Value
Fair Zone
10.37-14.29
Current Price：8.87
14.43%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Ardent Health Inc (ARDT) has a current Price-to-Book (P/B) ratio of 1.00. Compared to its 3-year average P/B ratio of 3.74 , the current P/B ratio is approximately -73.29% higher. Relative to its 5-year average P/B ratio of 3.74, the current P/B ratio is about -73.29% higher. Ardent Health Inc (ARDT) has a Forward Free Cash Flow (FCF) yield of approximately 12.73%. Compared to its 3-year average FCF yield of 6.23%, the current FCF yield is approximately 104.16% lower. Relative to its 5-year average FCF yield of 6.23% , the current FCF yield is about 104.16% lower.
P/B
Median3y
3.74
Median5y
3.74
FCF Yield
Median3y
6.23
Median5y
6.23
Competitors Valuation Multiple
AI Analysis for ARDT
The average P/S ratio for ARDT competitors is 0.33, providing a benchmark for relative valuation. Ardent Health Inc Corp (ARDT.N) exhibits a P/S ratio of 0.19, which is -43.04% above the industry average. Given its robust revenue growth of 8.75%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for ARDT
1Y
3Y
5Y
Market capitalization of ARDT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ARDT in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is ARDT currently overvalued or undervalued?
Ardent Health Inc (ARDT) is now in the Undervalued zone, suggesting that its current forward PE ratio of 6.68 is considered Undervalued compared with the five-year average of 8.38. The fair price of Ardent Health Inc (ARDT) is between 10.37 to 14.29 according to relative valuation methord. Compared to the current price of 8.87 USD , Ardent Health Inc is Undervalued By 14.43% .
What is Ardent Health Inc (ARDT) fair value?
ARDT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Ardent Health Inc (ARDT) is between 10.37 to 14.29 according to relative valuation methord.
How does ARDT's valuation metrics compare to the industry average?
The average P/S ratio for ARDT's competitors is 0.33, providing a benchmark for relative valuation. Ardent Health Inc Corp (ARDT) exhibits a P/S ratio of 0.19, which is -43.04% above the industry average. Given its robust revenue growth of 8.75%, this premium appears unsustainable.
What is the current P/B ratio for Ardent Health Inc (ARDT) as of Jan 10 2026?
As of Jan 10 2026, Ardent Health Inc (ARDT) has a P/B ratio of 1.00. This indicates that the market values ARDT at 1.00 times its book value.
What is the current FCF Yield for Ardent Health Inc (ARDT) as of Jan 10 2026?
As of Jan 10 2026, Ardent Health Inc (ARDT) has a FCF Yield of 12.73%. This means that for every dollar of Ardent Health Inc’s market capitalization, the company generates 12.73 cents in free cash flow.
What is the current Forward P/E ratio for Ardent Health Inc (ARDT) as of Jan 10 2026?
As of Jan 10 2026, Ardent Health Inc (ARDT) has a Forward P/E ratio of 6.68. This means the market is willing to pay $6.68 for every dollar of Ardent Health Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Ardent Health Inc (ARDT) as of Jan 10 2026?
As of Jan 10 2026, Ardent Health Inc (ARDT) has a Forward P/S ratio of 0.19. This means the market is valuing ARDT at $0.19 for every dollar of expected revenue over the next 12 months.